Morgan Stanley Knock-Out UCB/ DE000ME4U6P8 /
| 25/09/2024 21:14:42 | Chg.- | Bid09:17:46 | Ask09:17:46 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 9.78EUR | - | 9.58 Bid Size: 10,000 |
9.60 Ask Size: 10,000 |
UCB SA | 70.9243 EUR | 31/12/2078 | Call |
GlobeNewswire
26/08
Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice...
GlobeNewswire
26/08
MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign wi...
GlobeNewswire
15/08
United Community Banks, Inc. Announces Increased Quarterly Cash Dividend and Larger Share Repurchase...
GlobeNewswire
13/08
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Resul...
GlobeNewswire
26/07
United Community Banks, Inc. Announces Transfer of Listing of Common Stock and Depositary Shares to ...
GlobeNewswire
08/07
Conflicting Views Between Epileptologists and General Neurologists Hinder Adoption of New Refractory...
GlobeNewswire
28/06
United Community Banks, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference ...
GlobeNewswire
04/06
Chair of UC Berkeley Nuclear Engineering Department Joins NANO Nuclear Energy as Lead Developer of ‘...
GlobeNewswire
04/06
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
GlobeNewswire
03/06
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the...
GlobeNewswire
09/05
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire
01/05
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
15/04
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulpha...
GlobeNewswire
01/04
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire
25/03
Marathon Digital Holdings Releases Industry-Leading Bitcoin Mining Firmware and Control Board
GlobeNewswire
05/03
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire
05/03
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire
28/02
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire
16/02
United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
GlobeNewswire
08/02
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire
22/01
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilizati...
